Edition:
United States

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

4.07USD
1:34pm EST
Change (% chg)

$-0.01 (-0.25%)
Prev Close
$4.08
Open
$4.08
Day's High
$4.08
Day's Low
$4.07
Volume
409
Avg. Vol
1,950
52-wk High
$4.13
52-wk Low
$1.92

Select another date:

Mon, Dec 4 2017

BRIEF-Biomerica Enters Into At Market Issuance Sales Agreement With B. Riley FBR

* BIOMERICA INC - ‍ON DEC. 1, 2017, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC - SEC FILING​

BRIEF-Biomerica extends license agreement with Celtis Pharm

* Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

BRIEF-Biomerica Inc Q1 ‍net sales $1.4 million

* Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​

BRIEF-Biomerica commences clinical studies for new Gastroenterology H. Pylori test

* Biomerica commences clinical studies for new Gastroenterology H. Pylori test

BRIEF-Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company

* Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company

BRIEF-Biomerica files for stock shelf of up to $45 mln

* Biomerica Inc files for stock shelf of up to $45 million - SEC filing Source text: (http://bit.ly/2sqnkhi) Further company coverage:

Select another date: